Physician

Dan Sotirescu, M.D.

According to 2025 Medicare claims, Dan Sotirescu, M.D. (NPI: 1942209234) practices hematology/oncology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is CANCER CARE ASSOCIATES OF YORK, INC. (NPI: 1578587101; TIN: 232122436) and primary practice location at 17403-5049.

Sotirescu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 818 traditional Medicare patients, billed 156,847 HCPCS/CPT codes, and received $3,302,882 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 958 prescription claims across 211 beneficiaries totaling $765,227 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 18 records totaling $18,133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,120,031 and ending at $765,227. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $6,845 to $691.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	808	211,436	$2,404,132
2016	797	244,454	$2,829,775
2017	817	182,608	$2,845,101
2018	804	172,322	$2,572,556
2019	835	168,886	$2,933,061
2020	864	175,418	$2,667,454
2021	885	136,971	$2,687,101
2022	789	134,503	$2,749,998
2023	779	144,330	$2,523,844
2024	818	156,847	$3,302,882

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	238	1,111	$1,120,031
2016	270	1,197	$1,424,754
2017	256	1,006	$870,133
2018	265	1,034	$725,911
2019	242	911	$509,221
2020	184	878	$771,319
2021	195	843	$841,488
2022	195	856	$828,337
2023	213	930	$800,231
2024	211	958	$765,227

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	79	226	$65,578
2016	97	224	$8,204
2017	110	338	$30,408
2018	91	227	$13,491
2019	N/R	52	$4,743
2020	N/R	22	$3,686
2021	N/R	N/R	N/R
2022	N/R	12	$645
2023	N/R	N/R	N/R
2024	N/R	12	$524

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	284	672	$130
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	235	367	$12
80053	Blood test, comprehensive group of blood chemicals	302	915	$10
36415	Insertion of needle into vein for collection of blood sample	427	1,408	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	399	1,271	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	89	4,140	$79,383
Xarelto	Rivaroxaban	37	2,490	$43,456
Anastrozole	Anastrozole	58	4,424	$2,071
Tamoxifen Citrate	Tamoxifen Citrate	51	4,410	$1,465
Oxycodone Hcl	Oxycodone Hcl	12	288	$1,017

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	12	$524

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$8,133	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$10,000	PFIZER INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dan Sotirescu, M.D.?

Tedicare shows public-source Medicare data for Dan Sotirescu, M.D. (NPI 1942209234), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dan Sotirescu, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dan Sotirescu, M.D.?

Dan Sotirescu, M.D. is linked to CANCER CARE ASSOCIATES OF YORK, INC. (billing NPI 1578587101) in the available physician profile data.

Does Dan Sotirescu, M.D. have Open Payments data?

Dan Sotirescu, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.